凱發k8旗艦廳AG醫藥產品目錄諾氟沙星阿托伐他汀鈣（鈉）

產品展示

凱發k8旗艦廳AG藥業
凱發k8旗艦廳AG藥業原料藥凱發k8旗艦廳AG藥業中間體凱發k8旗艦廳AG藥業新藥凱發k8旗艦廳AG藥業製劑

凱發k8旗艦廳AG藥業中間體您現在的位置：首頁 > 產品展示 > 凱發k8旗艦廳AG藥業 > 凱發k8旗艦廳AG藥業中間體

序號	產品名稱	CAS	英文名	認證
1	3-氧代戊酸甲酯	30414-53-0	Methyl 3-oxo pentanoate
2	D.D.Q.	84-58-2	2, 3-Dichloro-5, 6-dicyano-1, 4-benzoquinone
3	3-氨基吡嗪-2-羧酸	5424-01-1	3-Aminopyrazine-2-carboxylic acid
4	S2	79560-19-3	4-(3, 4-Dichlorophenyl)-3, 4-dihydro-1-(2H)-naphthalene-1-one
5	T6	111974-74-4	11-piperazinyl-dibenzo[d,f][1,4]thiazepine dihydrochloride
6	順消旋鹽酸舍曲林	79559-97-0
7	半富馬酸喹硫平中間體	11974-74-4
8	F6	154477-55-1	Methyl 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-butyryl]-alpha, alpha-dimethylbenzene acetate
阿托伐他汀中間體係列
9	ATS-5: (R)-4-氰基-3-羥基丁酸乙酯	141942-85-0	(R) Ethyl-4-cyano-3-hydroxybutanoate
10	ATS-8: (4R-Cis)-6-氰甲基-2, 2-二甲基-1, 3-二氧己環-4-乙酸叔丁酯	125971-94-0	(4R-cis)-1,1-dimethylethyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate
11	ATS-9: (4R-Cis)-6-氨乙基-2, 2-二甲基-1, 3-二氧己環-4-乙酸叔丁酯	125995-13-3	(4R-cis)-1,1-dimethylethyl-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate
12	M1: 異丁酰乙酸乙酯	42558-54-3	Iso-butyryl methyl acetate
13	M-4: 4-氟-α-[2-甲基-1-氧丙基]-γ-氧代-N,β-二苯基苯丁酰胺	125971-96-2	4-Fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-N,β-diphenylbenzene butaneamide
14	L-1: (4R-cis)-6-[2-[2-(4-氟苯基)-5-(1-異丙基)-3-苯基-4- [(苯胺)羰基]-1H-吡咯-1-基]乙基]-2,2-二甲基-1, 3-二氧六環-4-乙酸叔丁酯	125971-95-1	(4R-cis)-1, 1-dimethylethyl-6-[2-[2-(4-fluorophenyl)-5-(1-isopropyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2, 2-dimethyl-1,3-dioxane-4-acetate	FDA DMF
氟伐他汀中間體係列
15	Q-2: 氟伐醇酮	93957-52-9	t-Butyl(E)-7-[3’-(4”-fluorophenyl)-1’-methylethyl-indol-2’-yl]-3-hydroxy-5-oxo-6-heptenoate
16	Q-3: 氟伐二醇	93957-53-0	t-Butyl(E)-3, 5-dihydroxy-7-[3’-(4”-fluorophenyl)-1’-methylethyl-indol-2’-yl]-6-heptenoate
多沙唑嗪中間體係列
17	1, 4-苯並二噁烷-2-羰基呱嗪鹽酸鹽	70918-74-0	N-(1, 4-benzodioxan-2-yl carbonyl)piperazine HCL
羅蘇伐他汀中間體係列
18	D-5: (4R-cis)-6-[(acetyloxy)methyl]-2，2-dimethyl-<BR>1，3-dioxane-4-acetic acid，1，1-dimethylethyl ester	154026-95-6	D-5: (4R-cis)-6-[(acetyloxy)methyl]-2，2-dimethyl-<BR>1，3-dioxane-4-acetic acid，1，1-dimethylethyl ester
19	D-6: (4R-cis)-6-hydroxymethyl-2, 2-dimethyl-1, 3- dioxane-4-acetic acid, 1, 1-dimethylethyl ester	124665-09-0	D-6: (4R-cis)-6-hydroxymethyl-2, 2-dimethyl-1, 3- dioxane-4-acetic acid, 1, 1-dimethylethyl ester
20	Z-5: Methyl 4-(4-fluorophenyl)-6-isopropyl-2-	160009-36-9	Z-5: Methyl 4-(4-fluorophenyl)-6-isopropyl-2-
21	Z-6: 4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl	289042-11-1	Z-6: 4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl
22	Z-7: 4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl	147118-36-3	Z-7: 4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl
23	Z-8: Diphenyl [4-(4-fluorophenyl)-6-isopropyl-2- [(N-methyl-N-methylsulfonyl) amino] pyrimidine-5- yl-methyl] phosphine oxide	289042-10-0	Z-8: Diphenyl [4-(4-fluorophenyl)-6-isopropyl-2- [(N-methyl-N-methylsulfonyl) amino] pyrimidine-5- yl-methyl] phosphine oxide
24	Z-8.1: 4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl -N-methylsulfonyl) amino] pyriminl-5-yl-formyl	147118-37-4	Z-8.1: 4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl -N-methylsulfonyl) amino] pyriminl-5-yl-formyl
25	J-6: Methyl(3R)-3-(tert-butyldimethylsilyloxy)-5-	147118-35-2	J-6: Methyl(3R)-3-(tert-butyldimethylsilyloxy)-5-
26	R-1: Tertiary-butyl-(+)-[(4-fluorophenyl)-6-isopropyl -2-(N-methyl, N-methyl sulphonyl amino) pyrimidine -5-yl]-(3R-5S)-dioxane-(E)-6 heptane	289042-12-2	R-1: Tertiary-butyl-(+)-[(4-fluorophenyl)-6-isopropyl -2-(N-methyl, N-methyl sulphonyl amino) pyrimidine -5-yl]-(3R-5S)-dioxane-(E)-6 heptane
27	R-1.5: (+)-(3R, 5S), tert-butyl 7-[4-(4-fluorophenyl)- 6-isopropyl-2-(N-methyl-N-methylsulphonylamino)- pyrimidine-5-yl]-3, 5-dihydroxy-6(E)-heptenate	355806-00-7	R-1.5: (+)-(3R, 5S), tert-butyl 7-[4-(4-fluorophenyl)- 6-isopropyl-2-(N-methyl-N-methylsulphonylamino)- pyrimidine-5-yl]-3, 5-dihydroxy-6(E)-heptenate	FDA DMF
28	R-2: Tert-butyl-(+) 7-[4-(4-fluorophenyl)-6-isopropyl -2-(N-methylsulfonylamino) pyrimidine-5-yl]-(3R, 5S)- dioxane-(E)-6-heptenate	287714-41-4	R-2: Tert-butyl-(+) 7-[4-(4-fluorophenyl)-6-isopropyl -2-(N-methylsulfonylamino) pyrimidine-5-yl]-(3R, 5S)- dioxane-(E)-6-heptenate
29	RJS-3: 7-[4-(4-氟苯基)-6-異丙基-2-(N-甲基-N-甲磺酰胺) 嘧啶-5-基]-(3R, 5R)-二羥基-(E)-6-庚烯酸甲酯	147118-40-9	Methyl 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N- methylsulfonylamino) pyrimidin-5-yl]-(3R, 5R)-dihydroxy- (E)-6-heptenate	FDA DMF

* Lab scale NOTE: All products above are not available in the patent covered areas.

此頁麵上的內容需要較新版本的 Adobe Flash Player。